CAMP Q1 2025 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$125M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$858,000

Gross Profit

$858,000100.0% margin

Operating Income

-$13M-1526.8% margin

Net Income

-$12M-1449.1% margin

EPS (Diluted)

$-0.64

QoQ Revenue Growth

+31.6%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$15M

Stock-Based Comp.

$861,000

Balance Sheet

Total Assets

$63M

Total Liabilities

$11M

Stockholders' Equity

$52M

Cash & Equivalents

$49M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$858,000	$0	—
Gross Profit	$858,000	$0	—
Operating Income	-$13M	-$13M	-1.7%
Net Income	-$12M	-$12M	+0.2%